{"pmid":32328576,"pmcid":"PMC7167497","title":"Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?","text":["Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?","Med Drug Discov","Cheng, Richard Z","32328576"],"journal":"Med Drug Discov","authors":["Cheng, Richard Z"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328576","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.medidd.2020.100028","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Ascorbic Acid"],"_version_":1664996914751340544,"score":8.518259,"similar":[{"pmid":32264963,"pmcid":"PMC7137406","title":"A new clinical trial to test high-dose vitamin C in patients with COVID-19.","text":["A new clinical trial to test high-dose vitamin C in patients with COVID-19.","Crit Care","Carr, Anitra C","32264963"],"journal":"Crit Care","authors":["Carr, Anitra C"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32264963","week":"202015|Apr 06 - Apr 12","doi":"10.1186/s13054-020-02851-4","link_comment_for":"29228951","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Ascorbic Acid"],"_version_":1664637636064575488,"score":95.061195},{"pmid":32258207,"pmcid":"PMC7111600","title":"High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.","text":["High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.","The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.","Open Forum Infect Dis","Cao, Wei","Liu, Xiaosheng","Bai, Tao","Fan, Hongwei","Hong, Ke","Song, Hui","Han, Yang","Lin, Ling","Ruan, Lianguo","Li, Taisheng","32258207"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19."],"journal":"Open Forum Infect Dis","authors":["Cao, Wei","Liu, Xiaosheng","Bai, Tao","Fan, Hongwei","Hong, Ke","Song, Hui","Han, Yang","Lin, Ling","Ruan, Lianguo","Li, Taisheng"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32258207","week":"202015|Apr 06 - Apr 12","doi":"10.1093/ofid/ofaa102","keywords":["coronavirus disease 2019","high-dose intravenous immunoglobulin","immunomodulation"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640769742340096,"score":91.09813},{"pmid":32322486,"pmcid":"PMC7172861","title":"Intravenous Vitamin C for reduction of cytokines storm in Acute Respiratory Distress Syndrome.","text":["Intravenous Vitamin C for reduction of cytokines storm in Acute Respiratory Distress Syndrome.","The recent outbreak of Covid19 has required urgent treatments for numerous patients. No suitable vaccines or antivirals are available for Covid19. The efficiency against Covid19 of WHO therapies of choice, that are two antivirals developed for other pathologies, is controversial. Therefore, alternative approaches are required. Intravenous (IV) Vitamin C (Vit-C) has emerged as one of the other alternatives for this purpose. Here we review the effects of IV Vit-C on the immune system response, the antiviral properties of IV Vit-C, and finally the antioxidant properties of IV Vit-C to specifically address the cytokines' storm characteristic of the Acute Respiratory Distress Syndrome (ARDS) that occur in the later cycle of the Covid19 infectious disease.","PharmaNutrition","Boretti, Alberto","Banik, Bimal Krishna","32322486"],"abstract":["The recent outbreak of Covid19 has required urgent treatments for numerous patients. No suitable vaccines or antivirals are available for Covid19. The efficiency against Covid19 of WHO therapies of choice, that are two antivirals developed for other pathologies, is controversial. Therefore, alternative approaches are required. Intravenous (IV) Vitamin C (Vit-C) has emerged as one of the other alternatives for this purpose. Here we review the effects of IV Vit-C on the immune system response, the antiviral properties of IV Vit-C, and finally the antioxidant properties of IV Vit-C to specifically address the cytokines' storm characteristic of the Acute Respiratory Distress Syndrome (ARDS) that occur in the later cycle of the Covid19 infectious disease."],"journal":"PharmaNutrition","authors":["Boretti, Alberto","Banik, Bimal Krishna"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322486","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.phanu.2020.100190","keywords":["antiviral agents","covid19","cytokines","severe acute respiratory syndrome coronavirus","vitamin c"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Ascorbic Acid"],"_version_":1664895932854960128,"score":84.65835},{"pmid":32281109,"title":"Letter: Covid-19, and vitamin D.","text":["Letter: Covid-19, and vitamin D.","Aliment Pharmacol Ther","Panarese, Alba","Shahini, Endrit","32281109"],"journal":"Aliment Pharmacol Ther","authors":["Panarese, Alba","Shahini, Endrit"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281109","week":"202016|Apr 13 - Apr 19","doi":"10.1111/apt.15752","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Vitamin D"],"_version_":1664636703984320513,"score":63.43001},{"pmid":32297519,"title":"COVID-19 and vitamin D-Is there a link and an opportunity for intervention?","text":["COVID-19 and vitamin D-Is there a link and an opportunity for intervention?","Am J Physiol Endocrinol Metab","Jakovac, Hrvoje","32297519"],"journal":"Am J Physiol Endocrinol Metab","authors":["Jakovac, Hrvoje"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297519","week":"202016|Apr 13 - Apr 19","doi":"10.1152/ajpendo.00138.2020","keywords":["ards","covid-19","sars-cov-2","immunomodulation","lung injury","vitamin d"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Vitamin D"],"_version_":1664641388349751298,"score":54.37199}]}